Compound ID | 642
| Spectrum of activity: | Antimycobacterial |
| Mechanism of action: | Unknown |
| Target Pathogen: | Active against Mycobacterium tuberculosis |
| Institute where first reported: | Pathogenesis Corp. (Chiron Corp., USA) |
| Year first mentioned: | 1997 |
| Development status: | Experimental |
| External links: | |
| PubChem link: | https://pubchem.ncbi.nlm.nih.gov/compound/476520 |
| Citation: | http://cdrwww.who.int/tdr/publications/documents/anti-tb-drug.pdf |